192 related articles for article (PubMed ID: 33166607)
1. Acyl and oligo(lactic acid) prodrugs for PEG-b-PLA and PEG-b-PCL nano-assemblies for injection.
Repp L; Rasoulianboroujeni M; Lee HJ; Kwon GS
J Control Release; 2021 Feb; 330():1004-1015. PubMed ID: 33166607
[TBL] [Abstract][Full Text] [Related]
2. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
Tam YT; Shin DH; Chen KE; Kwon GS
J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
[TBL] [Abstract][Full Text] [Related]
3. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
Tam YT; Gao J; Kwon GS
J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
[TBL] [Abstract][Full Text] [Related]
4. Oligo(Lactic Acid)
Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
[TBL] [Abstract][Full Text] [Related]
5. Stereocomplex Prodrugs of Oligo(lactic acid)
Tam YT; Huang C; Poellmann M; Kwon GS
ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
[TBL] [Abstract][Full Text] [Related]
6. Plasma Stability and Plasma Metabolite Concentration-Time Profiles of Oligo(Lactic Acid)
Repp L; Skoczen SL; Rasoulianboroujeni M; Stern ST; Kwon GS
AAPS J; 2023 Apr; 25(3):39. PubMed ID: 37041376
[TBL] [Abstract][Full Text] [Related]
7. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs.
Shin HC; Alani AW; Cho H; Bae Y; Kolesar JM; Kwon GS
Mol Pharm; 2011 Aug; 8(4):1257-65. PubMed ID: 21630670
[TBL] [Abstract][Full Text] [Related]
8. PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.
Cho H; Gao J; Kwon GS
J Control Release; 2016 Oct; 240():191-201. PubMed ID: 26699425
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.
Forrest ML; Yáñez JA; Remsberg CM; Ohgami Y; Kwon GS; Davies NM
Pharm Res; 2008 Jan; 25(1):194-206. PubMed ID: 17912488
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer.
Cho H; Lai TC; Kwon GS
J Control Release; 2013 Feb; 166(1):1-9. PubMed ID: 23246471
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
Kim SC; Kim DW; Shim YH; Bang JS; Oh HS; Wan Kim S; Seo MH
J Control Release; 2001 May; 72(1-3):191-202. PubMed ID: 11389998
[TBL] [Abstract][Full Text] [Related]
12. Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and
Safwat MA; Mansour HF; Hussein AK; Abdelwahab S; Soliman GM
Drug Deliv; 2020 Dec; 27(1):1115-1124. PubMed ID: 32720545
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
Shin HC; Cho H; Lai TC; Kozak KR; Kolesar JM; Kwon GS
J Control Release; 2012 Oct; 163(1):93-9. PubMed ID: 22549011
[TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
15. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles.
Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS
J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
[TBL] [Abstract][Full Text] [Related]
17. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
18. PEG-
Zhou T; Dong Q; Shen Y; Wu W; Wu H; Luo X; Liao X; Wang G
Int J Nanomedicine; 2016; 11():6517-6531. PubMed ID: 27980407
[TBL] [Abstract][Full Text] [Related]
19. Hypocrellin B-loaded, folate-conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo.
Li J; Yao S; Wang K; Lu Z; Su X; Li L; Yuan C; Feng J; Yan S; Kong B; Song K
Cancer Sci; 2018 Jun; 109(6):1958-1969. PubMed ID: 29617063
[TBL] [Abstract][Full Text] [Related]
20. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
